Researchers are desperately seeking viable alternatives to antibiotics. So what is phage therapy? And how could it help?

The new blood test could allow Parkinson’s disease to be diagnosed and treated earlier

The etiology of Parkinson's disease (PD) is multifactorial, with genetics, aging, and environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites, and degeneration of substantia nigra dopamine neurons are the …

Health workers who picked their noses were more likely to contract COVID, according to a new study. But here’s what the study means for the rest of us.

Bacteriophages have been a mainstay in medical centers abroad for some time now. Georgia’s Eliava Institute has been active since the 1930s. Yet countries including the U.S. and U.K. grant access almost exclusively under compassionate use. That means bacteriophages have been languishing for decades as a last-ditch option.

Thanks to CRISPR, farmers may finally have a good defense against rice blast, a fungal disease so devastating, it’s known as the “cancer of rice.”

Critical insights into why airborne viruses lose their infectivity have been uncovered by scientists at the University of Bristol. The findings, published in the Journal of the Royal Society Interface today [21 June], reveal how cleaner air kills the virus significantly quicker and why opening a window may be more important than originally thought. The research could shape future mitigation strategies for new viruses.

The fungal disease Panama TR4, which has no known cure or treatment, is confirmed on an eighth property in the Tully Valley.

The virulent Vibrio bacteria thrives in plastic, which intermingles with seaweed-like Sargassum washing up on beaches

Australian researchers have made a major leap forward, paving the way for the treatment of endometriosis, which could rapidly change health outcomes for women.

The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race against drugmakers Pfizer and Moderna to bring to market a shot that targets the respiratory syncytial virus.

Price gouging much?

Oropharyngeal cancer has now become more common than cervical cancer in the US and the UK.